| Virus |
| Avian influenza (H5N1) |
| Adenovirus |
| Beta 2 glycoprotein I (B2GPI) |
| Coronavirus (corona virus) |
| Crimean‐congo |
| Cytomegalovirus (CMV) |
| Dengue virus/dengue hemorrahic fever/dengue schock syndrome |
| Ebola |
| Epstein Barr (EBV) |
| Hantavirus |
| Hemorrhagic fever (hemorragic fever) |
| Hepatitis A/B/C (HAV, HBV, HCV) |
| Herpesvirus/herpes virus |
| Herpes simplex virus (HSV) |
| Human immunodeficiency virus (HIV) |
| Influenza |
| Junin (junin hemorrhagic fever) |
| Lassa/lassa fever |
| Marburg |
| Mexican flu (H1N1) |
| Parvovirus (B19) |
| Respiratory tract infections |
| Respiratory syncytial virus (RSV) |
| Rhinovirus |
| Severe acute respiratory syndrome (SARS) |
| Varicella zoster (VZV) |
| Viral hepatitis |
| Yellow fever |
| Coagulation |
| Activated protein C (APC) |
| Antiphospholipid antibodies/anticardiolipin antibodies/lupus anticoagulant |
| Antithrombin (AT) |
| Bleeding/hemorrhage/hemorrhage/bleeding complication |
| Coagulation |
| Coagulation factor/clotting factor |
| d‐dimer |
| Endothelial cell protein C receptor (EPCR) |
| Factor XI |
| Factor VIII |
| Fibrin/fibrinogen |
| Fibrinolysis |
| Hemorrhagic/hemorrhagic complications |
| Hemostasis/hemostasis |
| Heparin cofactor II |
| Heparan sulfate |
| Plasmin–α2‐antiplasmin (PAP) |
| Plasminogen activator inhibitor type I (PAI‐1) |
| Platelets |
| Protein C/protein S |
| Prothrombin fragment 1 + 2 (F1 + 2) |
| P‐selectin |
| Soluble intercellular adhesion molecule (sICAM) |
| Soluble vascular adhesion molecules (sVCAM) |
| Tissue factor (TF) |
| Tissue factor pathway inhibitor (TFPI) |
| TF‐factor VIIa |
| Thrombin–antithrombin (TAT) |
| Thrombin‐activatable fibrinolysis inhibitor (TAFI) |
| Thrombomodulin (TM) |
| Thrombosis/thrombotic complication |
| Tissue plasminogen activator (t‐PA) |
| von Willebrand factor (VWF) |
| Urokinase |